Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin Addition to Metformin and Pioglitazone in T2DM
NCT00885352Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Apr 2009
- Primary completion
- Nov 2010
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by Merck & Co.. Started Apr 2009; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00885352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00885352.